netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
 Formulary Chapter 2: Cardiovascular system - Full Chapter
Chapter Links...
 Details...
02.02.03  Expand sub section  Potassium-sparing diuretics and aldosterone antagonists
Amiloride tabs
View adult BNF View SPC online
Formulary  
   
02.02.03  Expand sub section  Aldosterone antagonists
Eplerenone tabs
View adult BNF View SPC online
Formulary

For signs and symptoms of heart failure after recent myocardial infarction as per NICE CG172.

Reserved for patients unable to tolerate spironolactone when used for the treatment of chronic heart failure with left ventricular dysfunction

 
Link  NICE CG108: Chronic heart failure
Link  NICE CG172 Myocardial Infarction: cardiac rehabilitation and secondary prevention
   
Spironolactone tabs
View adult BNF View SPC online
Formulary

Approved off-label indication:

Treatment of hypertension as per NICE CG127

 
Link  NICE CG108: Chronic heart failure
Link  NICE CG127: Hypertension in adults: diagnosis and management
   
Potassium canrenoate injection
View adult BNF View SPC online
Unlicensed Drug Unlicensed

Aldosterone antagonist.

Alternative to oral spironolactone

 
   
Spironolactone oral suspension
View adult BNF View SPC online
Unlicensed Drug Unlicensed

Oedema and ascites in liver cirrhosis, malignant ascites, nephrotic syndrome, congestive heart failure, primary hyperaldosteronism.

Dose: As for licensed oral doses for tablet formulation

 
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Specialist or hospital prescribing only. The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist or hospital. In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.   

Amber 1

Treatment can be initiated in primary care after a recommendation from an appropriate specialist  

Amber 2

Specialist initiation followed by maintenance prescribing in primary care  

Amber 3

Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation  

Green

Specialist and non-specialist initiation  

Grey

Not recommended for prescribing  

netFormulary